Foley & Lardner LLP recently represented New Enterprise Associates, Inc. as lead investor. Comanche Biopharma closed its $75 million Series B financing. New Enterprise Associates, Inc. acted...
Comanche Biopharma’s $75 Million Series B Financing Round
Fizz’s $25 Million Series B Funding Round
Foley & Lardner LLP represented New Enterprise Associates, Inc. on the matter. Fizz, the Gen Z-founded social media platform exclusively available for college students, raised $25...
Mozaic’s $20 Million Series A Funding Round
Foley & Lardner LLP represented Mozaic on the round. Mozaic, a global payment platform for multi-party payouts, announced its $20 million Series A funding round led...
Helium Health’s $30M Series B Funding
Foley & Lardner LLP represented Helium Health on the deal. Helium Health secured its $30 million Series B funding round. Helium Health is a Nigerian provider...
Flox’s $16.5M Series A Round
Foley & Lardner LLP represented New Enterprise Associates, Inc. on the deal. New Enterprise Associates, Inc. (NEA) acted as the lead investor in the $16.5 million...
Fizz’s $12 Million Series A Funding Round
Foley & Lardner LLP represented New Enterprise Associates (NEA) on the deal. New Enterprise Associates (NEA) acted the lead investor in the $12 million Series A funding...
Bamboo’s $15 Million Series A Financing
Foley & Lardner LLP represented Bamboo Inc. on the deal. Nigerian investment app Bamboo Inc. announced a $15 million Series A round co-led by Greycroft and...